This analysis revealed processes active in each subclone (Fig 6I), such as the de-regulation of CLDN18, previously reported in gastric cancer [41], and DHRS2, also associated with gastric carcinogenesis [42]. This evidence concerns the gene DHRS2 and gastric cancer.